Fortem Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$832K Buy
6,585
+221
+3% +$29.1K 0.17% 98
2026
Q1
$887K Buy
6,364
+639
+11% +$89.5K 0.22% 88
2025
Q4
$703K Sell
5,725
-303
-5% -$36.8K 0.19% 95
2025
Q3
$669K Sell
6,028
-281
-4% -$31.9K 0.19% 94
2025
Q2
$699K Sell
6,309
-115
-2% -$12.2K 0.23% 94
2025
Q1
$720K Sell
6,424
-246
-4% -$25.4K 0.28% 97
2024
Q4
$616K Buy
6,670
+407
+6% +$36.6K 0.24% 105
2024
Q3
$525K Sell
6,263
-2,689
-30% -$205K 0.21% 115
2024
Q2
$614K Sell
8,952
-544
-6% -$36.3K 0.26% 102
2024
Q1
$696K Buy
9,496
+1,444
+18% +$111K 0.31% 94
2023
Q4
$652K Sell
8,052
-84
-1% -$6.54K 0.32% 94
2023
Q3
$610K Sell
8,136
-926
-10% -$71.2K 0.36% 89
2023
Q2
$698K Buy
9,062
+874
+11% +$69.7K 0.41% 84
2023
Q1
$679K Sell
8,188
-559
-6% -$46.3K 0.44% 81
2022
Q4
$751K Buy
8,747
+21
+0.2% +$1.66K 0.44% 75
2022
Q3
$538K Sell
8,726
-977
-10% -$61.6K 0.37% 84
2022
Q2
$600K Buy
+9,703
New +$601K 0.39% 84
2021
Q1
Sell
-63
Closed -$4K 267
2020
Q4
$4K Buy
+63
New +$3.8K ﹤0.01% 416

Other funds holding GILD

Fortem Financial Group's GILD Position: Q2 2026 in Review

Fortem Financial Group increased its Gilead Sciences (GILD) stake by 3.5% in Q2 2026, buying an estimated $29.1K and bringing the position to 6,585 shares worth $832K. The position accounts for 0.17% of the portfolio, ranked #98.

Fortem Financial Group first reported a position in GILD in Q4 2020 and has held it in 18 quarters since. The position peaked at $887K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Fortem Financial Group held 6,585 shares of Gilead Sciences worth $832K as of Q2 2026.
  • Fortem Financial Group bought 221 Gilead Sciences shares in Q2 2026, an estimated $29.1K.
  • Gilead Sciences made up 0.17% of Fortem Financial Group's portfolio in Q2 2026, its #98 holding.
  • Fortem Financial Group first reported a position in Gilead Sciences in Q4 2020 and has held it in 18 quarters since.
  • Fortem Financial Group's Gilead Sciences position peaked at $887K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Fortem Financial Group's 13F filing for Q2 2026, filed 20 Jul 2026.